4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-016931
EVP and Chief Legal Officer sold 5,140 shares at $62.95 ($323,563)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Parschauer Karah Herdman EVP and Chief Legal Officer | 2022-03-07 | Sale | −5,140 | $62.95 | $323,563 | 34,438 | D: show line 1 in the form |
| Open-market sales · 5,140 sh · avg $62.95 · $323,563 | |||||||
Loading xslF345X03/doc4.xml…